Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
The Crohn’s & Colitis Foundation of America (CCFA) gave a recent update on its research initiative, the large-scale registry platform called IBD Plexus. ... Read more
Qu Biologics Inc. recently provided an update for ongoing clinical trials assessing the company’s lead candidate for inflammatory bowel diseases (IBD), namely ulcerative colitis ... Read more
Rebiotix Inc., a biotechnology company in Roseville, Minnesota, and McMaster Children’s Hospital, a pediatric academic health sciences center in Ontario, Canada, ... Read more
New data from researchers at the University of Wisconsin, Madison recently revealed that pregnant women with inflammatory bowel disease (IBD) are ... Read more
AbbVie recently announced the launch of the company’s Crohn’s & Colitis Scholarship, a set of grants with the goal of providing financial ... Read more
Janssen Biotech, Inc. and Janssen-Cilag International NV, both part of the Janssen Pharmaceutical Companies of Johnson & Johnson, recently announced the ... Read more
AstraZeneca recently announced an agreement with Perrigo Company plc regarding the divestment of rights for Entocort® (budesonide) in the United States. Entocort is ... Read more
Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies, recently announced the launch of a novel tool called Gut Check™, which ... Read more
